PlainPill

Dextroamphetamine

Also known as Dexedrine

The short answer. People are split on Dextroamphetamine — 43% of 81 say it helped. It is most often used for focus: 88% of 48 reports say that improved. It is well studied — 48 meta-analyses on PubMed. The most common complaint is anxiety.

What users report
43%helped81 reports · medium confidence
35 helped29 mixed17 didn't help

From 121 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
48
meta-analyses
119
RCTs
867
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Dextroamphetamine does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 48 meta-analyses on PubMed ↗ · 119 randomized trials ↗

PLoS One · 2020 · Meta-analysis / systematic review
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis

Conclusion: Overall, despite a class effect of improving clinical response relative to placebo, there were few differences among the individual ADHD pharmacotherapies, and most studies were at risk of at least one important source of bias. Furthermore, the certainty of the evidence was very low to low for all outcomes, and there was limited reporting of long-term adverse events. As such, the choice between ADHD pharmacotherapies may depend on individual patient considerations, and future studies should assess the long-term effects of individual pharmacotherapies on patient-important outcomes, including qu

PubMed 33085721 ↗
Registered clinical trials

202 human trials on ClinicalTrials.gov test Dextroamphetamine — 147 completed, 11 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US legal status (DEA)

Dextroamphetamine is a Schedule II controlled substance in the US (listed as Amphetamine). DEA controlled-substance list ↗

FDA drug label

Boxed warning (the FDA's strongest label warning): “ABUSE, MISUSE, AND ADDICTION Dextroamphetamine sulfate has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including dextroamphetamine sulfate, can result in overdose and death (see…”

Full label on DailyMed (NIH) ↗

FDA recalls

46 recalls of products named for Dextroamphetamine. Most recent:

  • 2026-07-08 · Class II: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. record ↗
  • 2025-10-01 · Class III: Failed Impurities/Degradation Specifications: record ↗
  • 2025-09-17 · Class II: Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and… record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

7,605 adverse-event reports mention Dextroamphetamine. Most often reported:

  • Drug ineffective · 1,013
  • Fatigue · 591
  • Nausea · 492
  • Anxiety · 475
  • Headache · 435
  • Depression · 417

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

US government research funding (NIH)

NIH has funded 3 research projects with Dextroamphetamine in the title, $146,143 in total (1985–2008). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Dextroamphetamine ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

anxiety ×3tolerance ×3insomnia ×3withdrawal ×2addiction ×2personality change ×2anhedonia ×2mania ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

Dextroamphetamine compared

Other options for focus

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate